ArticleCureus2026
Hyperleukocytosis in a Patient With Chronic Myeloid Leukemia and HIV: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coexistence of chronic myeloid leukemia (CML) and human immunodeficiency virus (HIV) presents a unique clinical challenge due to potential drug interactions and compounded side effects. This case report discusses a 55-year-old male with HIV and poorly managed CML, who presented with severe hyperleukocytosis. Potential leukostasis was managed using leukapheresis, hydroxyurea, and continued antiretroviral therapy before initiating dasatinib (a tyrosine kinase inhibitor), given its therapeutic effect on CML and potential properties to target HIV infection. This approach underscores the importance of rapid intervention, cytoreduction, and careful selection of therapy to minimize complications. Multidisciplinary coordination allowed for successful management, balancing leukemia and HIV treatment needs. This case emphasizes the complexity of CML-HIV co-treatment and the importance of tailored therapy, highlighting the need for further research on dual therapy impacts to improve outcomes and quality of life in co-infected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.